Biotech Values

[goodJohnhunting]

"Do you must use such BS to try in an effort to portray yourself as an expert on the PPHM board. I find it amusing"

Were you a member of the red neck comedy tour?

There's no portray, I just enjoy talking about Biotherapeutics, and I'm stooping to a new low just defending myself.

BTW since you missed the message, and I'm not surprised; when treating solid tumors with docetaxel, poor access "does" limit the fraction of tumor cells killed, thus reducing the effectiveness of chemo therapeutic drugs.

So when Bavituximab is activating an immune anti tumor response, and exposing a tumor for what it is (intrusive) Allowing the immune system to "stem the tide" and peel away layers of this solid malignancy, and by doing so improving the fraction of tumor cells killed via docetaxel. Well anyway, maybe even you should be able to visualize the cycle explained now?

And then again I could careless if you do. However, for those who actually understand the benefit, all the best!

John